In-depth phenotypic characterization, detailed treatment protocols, and a comprehensive review of published NR4A2 cases offer a thorough understanding of patients afflicted with intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism. The gene discussed is NR4A2; the disease is Dystonia.